Gennex Laboratories Ltd — Updates, 22-05-2025: Company Update

Gennex Laboratories’ subsidiary, Deccan Remedies Limited, has announced approvals to manufacture four additional pharmaceutical products—Tapentadol Hydrochloride, Etoricoxib, Nitazoxanide, and Voriconazole—valid for domestic and export markets until 2028. This expansion broadens the company’s product portfolio, potentially boosting revenue streams from both local and international sales. The approvals support Deccan Remedies’ manufacturing capabilities, enhancing its market presence and operational scale. Shareholders can view this as a strategic move to diversify offerings and tap into new growth opportunities.